Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Learn why financial indices are useful benchmarks, guide portfolio decisions, and help you compare performance across assets.
25,072 articlesA wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
When kevin warsh's inflation testimony landed, traders priced an 86% chance of a Fed rate hold. This article breaks d...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
A major investor liquidated a sizable stake as the decking stock down 35% over the past year. This article breaks dow...
An AI-led forecast suggests ripple (xrp) price prediction could push XRP to $500 by 2035, renewing debates about the ...
Ford stock has momentum, but the decision to buy isn’t straightforward. This article breaks down the case for and aga...
Domo's path to 2027 earnings hinges on expanding its customer base, increasing ARR, and managing margins in a competi...
As AMD gathers AI momentum and potential customer wins, july could month stock scenarios could tilt in favor of patie...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
Narrowing the lens on rare earths reveals how policy shifts, EV demand, and new mines could shape USA Rare Earth's st...
Palantir often looks pricey at first glance, but the real story may be hidden in growth engines and future contracts....
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...